CRISPR, the first FDA-approved treatment for sickle cell disease, may cure hundreds of African Americans. CRISPR has been making headlines for years but was only approved for clinical trials. Now, the product, Casgevy, manufactured by Vertex Pharmaceutics, is finally on the shelves. CRISPR […]
The post FDA Approves Cure for Sickle Cell Disease – First Treatment to Use Gene Editing Tool CRISPR first appeared on Good News Network.
Hundreds of African Americans may be cured of spear cell disease thanks to the second FDA-approved treatment using CRISPR. A CRISPR product that has been making headlines for years but has just been approved for trials is then, so to speak, on the shelves. This iteration of the treatment is called Casgevy and is produced by Vertex Pharmaceuticals. CRISPR.
The second article to appear on Good News Network was titled “FDA Approves Cure for Sickle Cell Disease, the First Treatment to Use Gene-Editing Tool CRISPR.”
